HopeStage
Back to all studies
TerminatedNCT01051440

Magnetic Resonance Imaging Study of Lisdexamfetamine for Depression in bipolarity

Medication studyAges 21–50United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 21 years to 50 years.

Listed locations
BostonSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateFebruary 2010
Recruitment status
Terminated
Enrollment listed in the registry
2
Sponsor
Steward St. Elizabeth's Medical Center of Boston, Inc.
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 21 Years to 50 Years
Official registry ID
NCT01051440
Official title
Show the full official title

A Magnetic Resonance Spectroscopy and fMRI Study of the Effects of Lisdexamfetamine on Bipolar Depression

Recruitment & locations

Terminated

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Steward St. Elizabeth's Medical Center of Boston, Inc., a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Lisdexamfetamine and Placebo.

Who can participate?

Listed age limits: 21 years to 50 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies